Genzyme reports 4Q and full year 2005 financial results
- Publisher
- Elsevier Science
- Year
- 2006
- Weight
- 51 KB
- Volume
- 2006
- Category
- Article
- ISSN
- 1351-4180
No coin nor oath required. For personal study only.
โฆ Synopsis
construction of a catalyst unit in the Middle East, and intends to expand its catalysts operations in Asia. Albemarle will commission a catalyst repackaging plant in China by May 2006. To meet soaring demands in North America, the company is evaluating plans to increase cGMP capacity at its Orangeburg site. A minor expansion at its cGMP unit at Dayton in Ohio, USA was completed in Feb 2006.
๐ SIMILAR VOLUMES
In view of the economic environment, Novozymes considers its current 2009 growth outlook satisfactory. The slowdown in 4Q 2008 is not considered a reliable indicator of 2009 full-year performance. Sales growth is forecast at 8-13% (in terms of DKR), and operating profit is expected to grow by 10-15%